Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma. [electronic resource]
Producer: 20181026Description: 92-94 p. digitalISSN:- 2168-6084
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cell Death
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Nivolumab
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Skin Neoplasms -- drug therapy
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.